Sign in

CIK 0001444192

  • Non-accelerated filer
  • Smaller reporting company

Grace Therapeutics, Inc.

Sign in to watch
Ticker
GRCE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
Phone
+1 609-322-1602
Business address
103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
Former names
Acasti Pharma Inc.
Open-market buys, last 90 days
$814,975
in 11 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Opaleye Management Inc. +$601K 10% owner 10 filings
  2. Kohli Prashant +$214K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-09-17 Kavuru Vimal Director Grant or award · Stock Option (Right to Buy) +12,200 12,200
2026-01-08 Kavuru Vimal Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2025-05-09 Kavuru Vimal Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-12-19 Kavuru Vimal Director Grant or award · Stock Options (Right to Buy) +10,000 10,000
2023-09-25 Kavuru Vimal Director Purchase +676,371 $1.85 $1.2M 1,188,076
2023-09-25 Kavuru Vimal Director Purchase · Common Warrants (right to buy) +422,732 $0.13 $53K 422,732
2023-07-14 Kavuru Vimal Director Grant or award · Stock Options (Right to Buy) +12,500 12,500
2022-09-28 Kavuru Vimal Director Grant or award · Stock Options (Right to Buy) +45,000 45,000
2021-11-12 Kavuru Vimal Director Grant or award · Stock Options (Right to Buy) +42,100 42,100

Page 1 of 1 · 9 trades